Of note, Jurkat cell-derived CM, which was generated from the overexpression of c-Myc/Oct4 as well as Sox2/Klf4 did not induce detectable changes in MTT-based viability and transwell invasion in 4T1.2 mammary tumor cells (Figure 5E-F). The gene discussed is MYC; the disease is breast cancer.